1CM
CDNA icon

1492 Capital Management’s CareDx CDNA Stock Holding History

1492 Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$218K Buy
+12,534
New +$237K 0.08% 124

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

1492 Capital Management's CDNA Position: Q1 2026 in Review

1492 Capital Management opened a new position in CareDx (CDNA) in Q1 2026: 12,534 shares worth $218K. The stake represents 0.08% of the portfolio and ranks #124 among its holdings.

190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • 1492 Capital Management held 12,534 shares of CareDx worth $218K as of Q1 2026.
  • CareDx was a new 1492 Capital Management position in Q1 2026.
  • CareDx made up 0.08% of 1492 Capital Management's portfolio in Q1 2026, its #124 holding.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on 1492 Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.